Accutane (isotretinoin) is the most effective acne treatment available, and it’s not particularly close. In a large network meta-analysis of 221 randomized controlled trials, oral isotretinoin ranked first among all pharmacological acne treatments, outperforming every combination of antibiotics, topical retinoids, and benzoyl peroxide. About 96% of patients achieve complete or near-complete clearance by the end of a single course, and roughly three out of four people stay clear long-term without needing further treatment.
How It Compares to Other Treatments
Isotretinoin’s effectiveness stands well apart from alternatives. In the meta-analysis published in the Annals of Family Medicine, isotretinoin reduced inflammatory acne lesions by a mean difference of 48.41 compared to placebo. The next best option, a triple combination of a topical antibiotic, topical retinoid, and benzoyl peroxide, scored 38.15. The best-performing oral antibiotic, doxycycline, managed only 16.05 as a standalone treatment.
Hormonal treatments like birth control pills vary widely in effectiveness, with the best-performing combination reaching a score of about 26, still roughly half as effective as isotretinoin. Antibiotic monotherapies were generally the weakest performers, and several, including oral azithromycin and topical minocycline, didn’t show significant superiority over placebo at all.
What makes isotretinoin unique is that it’s the only acne medication that addresses all four underlying causes of acne at once: excess oil production, clogged pores, bacterial growth, and inflammation. It does this primarily by shrinking the oil-producing glands in your skin and dramatically reducing their activity. This is also why its results tend to be lasting, unlike antibiotics or topical treatments that only work while you’re using them.
What Clearance Rates Actually Look Like
In clinical studies, roughly 96% of patients see complete clearance, defined as no acne or only occasional isolated pimples, by the time they finish their course. That number holds across a range of dosing strategies, from standard doses to lower daily amounts. The American Academy of Dermatology strongly recommends isotretinoin for acne that is severe, causing scarring, creating significant psychological distress, or failing to respond to standard treatments like antibiotics and topical therapies.
For severe, deep cystic acne specifically, isotretinoin remains the gold standard. It consistently outperforms alternatives not just in clearing active breakouts but in preventing the kind of permanent scarring that cystic acne causes. A comparison trial found isotretinoin superior to oral dapsone (another systemic option sometimes tried for resistant cases) in reducing oil production, altering skin bacteria, and producing long-lasting remission after treatment ends.
Long-Term Remission and Relapse
One of the most important questions people have is whether their acne will come back. A large cohort study of nearly 20,000 patients found that 77.5% did not experience acne relapse after a single course of isotretinoin. Of the 22.5% who did relapse, most had milder breakouts that responded to standard topical treatments. Only 8.2% of the entire group needed a second round of isotretinoin.
This prolonged remission is what sets isotretinoin apart from every other acne treatment. Antibiotics suppress acne while you take them, but breakouts commonly return once you stop. Isotretinoin physically changes the oil glands in your skin, shrinking them in both size and metabolic activity, which is why results persist months and years after you’ve finished treatment.
How Long Treatment Takes
A standard course lasts about four to six months. The traditional approach uses a dose of 0.5 to 1 mg per kilogram of body weight per day until you reach a cumulative total dose of 120 to 140 mg per kilogram. There’s growing evidence that lower daily doses (as low as 5 mg per day) can be equally effective with fewer side effects, though this means a longer treatment course to reach the same cumulative amount.
Most people don’t see dramatic improvement in the first few weeks. In fact, many experience an initial flare, sometimes called the “purging phase,” where acne temporarily worsens before it gets better. This tends to happen within the first month and is more common in people with deep cystic lesions. It can be discouraging, but it’s a normal part of how the drug works as it accelerates skin cell turnover. Meaningful, visible improvement typically becomes apparent by the second or third month, with continued clearing through the rest of the course.
Who Benefits Most
Isotretinoin is most commonly prescribed for severe or cystic acne, but it’s not limited to the worst cases. It’s also appropriate for moderate acne that keeps coming back despite other treatments, acne that’s leaving scars even if it doesn’t look extreme on the surface, and acne causing significant emotional distress. The clinical guidelines reflect this broader use: the threshold isn’t just severity but also how well your skin responds to other options and how much acne is affecting your life.
The drug does come with well-known side effects, the most universal being dry skin, dry lips, and dry eyes. These are predictable consequences of how it reduces oil gland activity and affect nearly everyone on treatment to some degree. More serious potential side effects exist, which is why isotretinoin requires regular monitoring through blood tests and close follow-up with a dermatologist throughout the course. For women of childbearing age, strict pregnancy prevention is required because isotretinoin causes severe birth defects.
Despite the monitoring requirements and side effects, isotretinoin’s effectiveness profile is unmatched. For people who have cycled through antibiotics, topical creams, and other treatments without lasting results, it offers something no other acne medication can: a realistic chance of permanent or near-permanent resolution in a single course lasting just a few months.